Distinction between processing of normal and mutant complement C3 within human skin fibroblasts

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 845-855

  Fishelson, Zvi ^a   Kozer, Eran ^b   Sirhan, Saleh ^a   Katz, Yitzhak ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

C3; Complement; Degradation; Endoplasmic reticulum retention; Synthesis

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMMONIUM CHLORIDE; COMPLEMENT COMPONENT C3; MUTANT PROTEIN;

ARTICLE; COMPLEMENT DEFICIENCY; CYTOPLASM; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOGENETICS; LYSOSOME; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROCESSING; SKIN FIBROBLAST; TEMPERATURE;

EID: 0033056842     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199903)29:03<845::AID-IMMU845>3.0.CO;2-X     Document Type: Article

References (55)

1. Rother, K., Till, G. O. and Hansch, G. M. (Eds.) The Complement System. Springer-Verlag, Berlin 1998.
2. Colten, H. R. and Rosen, F. S., Complement deficiencies. Annu. Rev. Immunol. 1992. 10: 809-834.
3. Lambris, J. D., Sahu, A. and Wetsel, R. A., The chemistry and biology of C3, C4 and C5, In Volanakis, J. E. and Frank, M. M. (Eds.) The Human Complement System in Health and Disease. Marcel Dekker, New York 1998, pp 83-118.
4. Fishelson, Z., Complement C3: a molecular mosaic of binding sites. Mol. Immunol. 1991. 28: 545-552.
5. Peleg, D., Harit-Bustan, H., Katz, Y., Peller, Schlesinger, S. M. and Schonfeld, S., Inherited C3 deficiency and meningococcal disease in a teenager. Pediatr. Infect. Dis. J. 1992. 11: 401-404.
6. Singer, L., Whitehead, W. T., Akama, H., Katz, Y., Fishelson, Z. and Wetsel, R. A., Inherited human complement C3 deficiency. An amino acid substitution in the β-chain (ASP549 to ASN) impairs C3 secretion. J. Biol. Chem. 1994. 269: 28494-28499.
7. Katz, Y., Wetsel, R. A., Schlesinger, M. and Fishelson, Z., Compound heterozygous complement C3 deficiency. Immunology 1995. 94: 5-7.
8. Katz, Y., Singer, L., Wetsel, R. A., Schlesinger, M. and Fishelson, Z., Inherited complement C3 deficiency: a defect in C3 secretion. Eur. J. Immunol. 1994. 24: 1517-1522.
9. Alper, C. A., Johnson, A. M., Birtch, A. G. and Moore, F. D., Human C'3: Evidence for the liver as the primary site of synthesis. Science 1969. 163: 286-288.
10. Naughton, M. A., Botto, M., Carter, M. J., Alexander, G. J. M., Goldman, J. M. and Walport, M. J., Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J. Immunol. 1996. 156: 3051-3056.
11. Katz, Y. and Strunk, R. C., IL-1 and tumor necrosis factor: similarities and differences in stimulation of expression of alternative pathway of complement and INF-β2/ IL-6 genes in human fibroblasts. J. Immunol. 1989. 142: 3862-3867.
12. Volanakis, J. E., Transcriptional regulation of complement genes. Annu. Rev. Immunol. 1995. 13: 277-305.
13. Whitehead, A. S., Solomon, E., Chambers, S., Bodmer, W. F., Povey, S. and Fey, G., Assignment of the structural gene for the third component of human complement to chromosome 19. Proc. Natl. Acad. Sci. USA 1982. 79: 5021-5025.
14. Fong, K. Y., Botto, M., Walport, M. J. and So, A. K., Genomic organization of human complement component C3. Genomics. 1990. 7: 579-586.
15. Vik, D. P., Amiguet, P., Moffat, G. J., Fey, M., Amiguet-Barras, F., Wetsel, R. A. and Tack, B. F., Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence. Biochemistry 1991. 30: 1080-1085.
16. Brade, V., Hall, R. E. and Colten, H. R., Biosynthesis of pro-C3, a precursor of the third component of complement. J. Exp. Med. 1977. 146: 759-765.
17. de Bruijn, M. H. and Fey, G. H., Human complement component C3: cDNA coding sequence and derived primary structure. Proc. Natl. Acad. Sci. USA 1985. 82: 708-712.
18. Tomana, M., Niemann, M., Garner, C. and Volanakis, J. E., Carbohydrate composition of the second, third and fifth components and factors B and D of human complement. Mol. Immunol. 1985. 22: 107-111.
19. Hase, S., Kikuchi, N., Ikenaka, T. and Inoue, K., Structures of sugar chains of the third component of human complement. J. Biochem. (Tokyo) 1985. 98: 863-874.
20. Hirani, S., Lambris, J. D. and Muller-Eberhard, H. J., Structural analysis of the asparagine-linked oligosaccharides of human complement component C3. Biochem. J. 1986. 233: 613-616.
21. Oda, K., Misumi, Y., Ikehara, Y., Brennan, S. O., Hatsuzawa, K. and Nakayama, K., Proteolytic cleavages of proalbumin and complement Pro-C3 in vitro by a truncated soluble form of furin, a mammalian homologue of the yeast Kex2 protease. Biochem. Biophys. Res. Commun. 1992. 189: 1353-1361.
22. Morris, K. M., Goldberger, G., Colten, H. R., Aden, D. P. and Knowles, B. B., Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line. Science 1982. 215: 399-400.
23. Dolmer, K. and Sottrup-Jensen, L., Disulfide bridges in human complement component C3b. FEBS Lett. 1993. 315: 85-90.
24. Gething, M.-J. and Sambrook, J., Protein folding in the cell. Nature 1992. 355: 33-45.
25. Griffiths, G., Pfeiffer, S., Simons, K. and Matlin, K., Exit of newly synthesized membrane proteins from the trans cisterna of the Golgi complex to the plasma membrane. J. Cell Biol. 1985. 101: 949-964.
26. Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A. and Ikehara, Y., Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 1988. 263: 18545-18552.
27. Perkins, S. J., Smith, K. F., Amatayakul, S., Ashford, D., Rademacher, T. W., Dwek, R. A., Lachmann, P. J. and Harrison, R. A., Two-domain structure of the native and reactive centre cleaved forms of C1 inhibitor of human complement by neutron scattering. J. Mol. Biol. 1990. 214: 751-763.
28. Botto, M. and Walport, M. J., Inherited deficiency of C3 in animals and humans. Int. Rev. Immunol. 1993. 10: 37-50.
29. Huang, J. L. and Lin, C. Y., A hereditary C3 deficiency due to aberrant splicing of exon 10. Clin. Immunol. Immunopathol. 1994. 73: 267-273.
30. Singer, L., Van-Hee, M. L., Lokki, M. L., Kramer, J., Borzy, M. S. and Wetsel, R. A., Inherited complement C3 deficiency: reduced C3 mRNA and protein levels in a Laotian kindred. Clin. Immunol. Immunopathol. 1996. 81: 244-252.
31. Oda, K., Calcium depletion blocks proteolytic cleavages of plasma protein precursors which occur at the Golgi and/or trans-Golgi network. Possible involvement of Ca(2+)-dependent Golgi endoproteases. J. Biol. Chem. 1992. 267: 17465-17471.
32. Fujiwara, T., Takami, N., Misumi, Y. and Ikehara, Y., Nordihydroguaiaretic acid blocks protein transport in the secretory pathway causing redistribution of Golgi proteins into the endoplasmic reticulum. J. Biol. Chem. 1998. 273: 3068-3075.
33. Misumi, Y., Takami, N. and Ikehara, Y., Biosynthesis and processing of pro-C3, a precursor of the third component of complement in rat hepatocytes: effect of secretion-blocking agents. FEBS Lett. 1984. 175: 63-67.
34. Chanat, E. and Huttner, W. B., Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. J. Cell Biol. 1991. 115: 1505-1519.
35. Urbe, S., Dittie, A. S. and Tooze, S. A., pH-dependent processing of secretogranin Il by the endopeptidase PC2 in isolated immature secretory granules. Biochem. J. 1997. 321: 65-74.
36. Brennan, S. O. and Peach, R. J., Calcium-dependent KEX2-like protease found in hepatic secretory vesicles converts proalbumin to albumin. FEBS Lett. 1988. 229: 167-170.
37. Molloy, S. S., Thomas, L., Van Slyke, J. K., Stenberg, P. E. and Thomas, G., Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. EMBO J. 1994. 13: 18-33.
38. Dittie, A. S., Thomas, L., Thomas, G. and Tooze, S. A., Interaction of furin in immature secretory granules from neuroendocrine cells with the AP-1 adaptor complex is modulated by casein kinase II phosphorylation. EMBO J. 1997. 16: 4859-4870.
39. David, V., Hochstenbach, F., Rajagopalan, S. and Brenner, M. B., Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). J. Biol. Chem. 1993. 268: 9585-9592.
40. Hammond, C. and Helenius, A., Folding of VSV G protein: sequential interaction with BiP and calnexin. Science 1994. 266: 456-458.
41. Liu, Y., Choudhury, C., Cabral, P. M. and Sifers, R. N., Intracellular disposal of incompletely folded human alpha 1-antitrypsin involves release from calnexin and post-translational trimming of asparagine-linked oligosaccharides. J. Biol. Chem. 1997. 272: 7946-7951.
42. Qu, D., Teckman, J. H., Omura, S. and Perlmutter, D. H., Degradation of a mutant secretory protein, alpha 1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J. Biol. Chem. 1996. 271: 22791-22795.
43. Shenkman, M., Ayalon, M. and Lederkremer, G. Z., Endoplasmic reticulum quality control of asialoglycoprotein receptor H2a involves a determinant for retention and not retrieval. Proc. Natl. Acad. Sci. USA 1997. 94: 11363-11368.
44. Yu, H., Kaung, G., Kobayashi, S. and Kopito, R. R., Cytosolic degradation of T-cell receptor alpha chains by the proteasome. J. Biol. Chem. 1997. 272: 20800-20804.
45. Jackson, M. R., Cohen-Doyle, M. F., Peterson, P. A. and Williams, D. B., Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science 1994. 263: 384-387.
46. Rajagopalan, S. and Brenner, M. B., Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum. J. Exp. Med. 1994. 180: 407-412.
47. Tsukamoto, H., Tousson, A., Marchase, R. B. and Volanakis, J. E., Regulation of intracellular transport of C2 by calnexin, a molecular chaperone. Mol. Immunol. 1996. 33, Supp. 1: 16 (abstract).
48. Vassilakos, A., Cohen-Doyle, M. F., Peterson, P. A., Jackson, M. R. and Williams, D. B., The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 1996. 15: 1495-1506.
49. Ye, S. Q., Reardon, C. A. and Getz, G. S., Inhibition of apolipoprotein E degradation in a post-Golgi compartment by a cystein protease inhibitor. J. Biol. Chem. 1993. 268: 8497-8502.
50. Hiller, M. M., Finger, A., Schweiger, M. and Wolf, D. H., ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 1996. 273: 1725-1728.
51. Ward, C. L., Omura, S. and Kopito, R. R., Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 1995. 83: 121-127.
52. Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L. and Riordan, J. R., Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 1995. 83: 129-135.
53. Plemper, R. K., Bohmler, S., Bordallo, J., Sommer, T. and Wolf, D. H., Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature 1997. 388: 891-895.
54. Katz, Y., Cole, F. S. and Strunk, R. C., Synergism between gamma Interferon and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblasts. J. Exp. Med. 1988. 167: 1-14.
55. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970. 227: 680-685.